1[1]Adinoff AD, Hollister JR. Steroid - induced fractures and bone loss in patients with asthma. N Engl Med, 1983,309:265 -268. 被引量：1
2[2]Garton M J, Rein DM. Bone mineral density of the hip and of the antero- posterior and lateral dimension of the spine in men with rheumatoid arthritis. Arthritis Rheum, 1993,36:202 - 211. 被引量：1
3[3]Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin:a novel secreted protein in involved in the regulation of bone density.Cell, 1997,89:309 - 319. 被引量：1
5[5]Morony S, Capparelli C, Lee R, et al. A chimeric form of osteoprotegerin inhibits hypercalcemia and bone resorption induced by IL1beta, TNF alpha, PTH, PTHrP, and 1,25(OH)2D3. J Bone Miner Res, 1999,14:1478 - 1485. 被引量：1
6[6]Tomoyasu A, Goto M, Fujise N, et al. Characterization of monomeric and homodimeric forms of osteoclastogenesis inhibitory factor.Biochem Biophys Res Commun, 1998,245:382 - 3597. 被引量：1
7[7]Hofbauer LC, Heufelder AE. The role of receptor activator of nuclear factor kapper B ligand and osteoprotegerin in the pathogenesis and treatment of metabolic bone diseases. J Clin Endocr Metab,2000,85:2355 - 2364. 被引量：1
8[8]Akatsu T, Murakami T, Nishikawa M, et al. Osteoclastagenesis inhibitory factor suppresses osteoclast survival by incterfering in the interaction of stromal cells with osteoclast. Biochem Biophys Res Commun, 1998, 250:229 - 234. 被引量：1
9[9]Hofboauer LC, Khosla S, Dunstan CR, et al. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res,2000,15:212 - 213. 被引量：1
10[10]Haas M, Leko - Mohr Z, Roschger P. Osteoprotegerin and parathyroid hormone as markers of high - turnover osteodystrophy and decreased bone mineralization in hemodialysis patients. Am J Kidney,2002,39:580 - 586. 被引量：1
